Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2.
about
Targeting osteosarcoma vasculature with peptide obtained by phage displayA high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes.In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells.The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.Anti-tumoral effects of exercise on hepatocellular carcinoma growth.
P2860
Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@ast
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@en
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@nl
type
label
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@ast
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@en
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@nl
prefLabel
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@ast
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@en
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@nl
P2093
P2860
P1476
Effects on hepatocellular carc ...... esigned to target the VEGFR-2.
@en
P2093
Anne-Christine Piguet
Caroline Hammer
Ernst Waelti
Monika Ledermann
Patrik Roth
P2860
P304
P356
10.1080/10611860701502723
P577
2007-11-01T00:00:00Z